MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Tenet Healthcare Corp Company Profile (NYSE:THC)

Consensus Ratings for Tenet Healthcare Corp (NYSE:THC) (?)
Ratings Breakdown: 6 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $62.70 (11.37% upside)

Current Analysts' Coverage Summary for Tenet Healthcare Corp (NYSE:THC)
Show:
DateFirmActionRatingPrice TargetActions
7/22/2015Goldman SachsInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015MizuhoReiterated RatingBuy$68.20View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Jefferies GroupReiterated RatingBuy$63.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Wells Fargo & Co.UpgradeMarket Perform -> Outperform$74.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2015WedbushInitiated CoverageOutperform$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015SunTrustReiterated RatingHold$52.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Deutsche BankReiterated RatingBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$66.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$59.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015BarclaysLower Price TargetOverweight$65.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014Robert W. BairdBoost Price TargetOutperform$65.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014RBC CapitalBoost Price TargetSector Perform$43.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014Credit SuisseReiterated RatingNeutral$51.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014Raymond JamesUpgradeMarket Perform -> Outperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2014S&P Equity ResearchDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014FBR & Co.Boost Price TargetMarket Perform$45.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2014Monness Crespi & HardtInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014SusquehannaDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014CRT CapitalDowngradeBuy -> Fair Value$51.00 -> $41.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha